ATE409066T1 - Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit - Google Patents

Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit

Info

Publication number: ATE409066T1
Authority: AT; Austria
Prior art keywords: infertility; treatment; single dose; aromatase inhibitor; aromatase
Prior art date: 2001-04-17

Application number

AT02717919T

Other languages

English (en)

Inventor

Robert Casper

Mohamed Mitwally

Original Assignee

Ares Trading Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-17

Filing date

2002-04-17

Publication date

2008-10-15

2002-04-17 Application filed by Ares Trading Sa filed Critical Ares Trading Sa

2008-10-15 Application granted granted Critical

2008-10-15 Publication of ATE409066T1 publication Critical patent/ATE409066T1/de

Links

229940122815 Aromatase inhibitor Drugs 0.000 title 1
239000003886 aromatase inhibitor Substances 0.000 title 1
208000000509 infertility Diseases 0.000 title 1
230000036512 infertility Effects 0.000 title 1
231100000535 infertility Toxicity 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT02717919T 2001-04-17 2002-04-17 Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit ATE409066T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28428201P	2001-04-17	2001-04-17

Publications (1)

Publication Number	Publication Date
ATE409066T1 true ATE409066T1 (de)	2008-10-15

Family

ID=23089583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02717919T ATE409066T1 (de)	2001-04-17	2002-04-17	Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit

Country Status (32)

Country	Link
US (1)	US8008333B2 (de)
EP (1)	EP1383578B1 (de)
JP (1)	JP2004529924A (de)
KR (1)	KR20040025916A (de)
CN (1)	CN1551789A (de)
AR (1)	AR034036A1 (de)
AT (1)	ATE409066T1 (de)
AU (1)	AU2002249043B2 (de)
BG (1)	BG108323A (de)
BR (1)	BR0208920A (de)
CA (1)	CA2444980C (de)
CY (1)	CY1108648T1 (de)
CZ (1)	CZ20033107A3 (de)
DE (1)	DE60229047D1 (de)
DK (1)	DK1383578T3 (de)
EA (1)	EA011310B1 (de)
EE (1)	EE200300505A (de)
ES (1)	ES2311599T3 (de)
HR (1)	HRP20030839A2 (de)
HU (1)	HUP0304003A2 (de)
IL (1)	IL158396A0 (de)
MX (1)	MXPA03009447A (de)
NO (1)	NO20034246L (de)
NZ (1)	NZ552873A (de)
PL (1)	PL366744A1 (de)
PT (1)	PT1383578E (de)
SI (1)	SI1383578T1 (de)
SK (1)	SK14242003A3 (de)
UA (1)	UA82648C2 (de)
WO (1)	WO2002083241A1 (de)
YU (1)	YU81203A (de)
ZA (1)	ZA200307516B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004004634A2 (en) *	2002-07-02	2004-01-15	Pharmacia & Upjohn Company Llc	Infertility treatment with exemestane
EA200501548A1 (ru)	2003-04-01	2006-02-24	Апплайд Резеч Системз Арс Холдинг Н.В.	Ингибиторы фосфодиэстераз при бесплодии
WO2007000056A1 (en) *	2005-06-28	2007-01-04	Casper Robert F	Aromatase inhibitors for emergency contraception
WO2007081980A2 (en) *	2006-01-10	2007-07-19	Diobex, Inc.	Methods and compositions for treating prostate cancer
AU2011256088B2 (en) *	2010-05-20	2015-03-26	University Of Saskatchewan	Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
WO2014169395A1 (en)	2013-04-19	2014-10-23	University Of Saskatchewan	Aromatase inhibitor-releasing intravaginal device
US20160022644A1 (en) *	2014-07-22	2016-01-28	Tsu-I Catherine Wang	Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4728645A (en) *	1982-12-21	1988-03-01	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4602025A (en) *	1984-06-18	1986-07-22	Eli Lilly And Company	Aromatase inhibitors
US4845227A (en) *	1984-06-18	1989-07-04	Eli Lilly And Company	Aromatase inhibitors from azoles
US4978672A (en) *	1986-03-07	1990-12-18	Ciba-Geigy Corporation	Alpha-heterocyclc substituted tolunitriles
GB8726505D0 (en) *	1987-11-12	1987-12-16	Ici Plc	Naphtho(2 1-b)furan derivatives
DE4330237C2 (de)	1993-09-02	1995-11-30	Schering Ag	1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
WO1997040846A1 (en) *	1996-04-30	1997-11-06	Takeda Chemical Industries, Ltd.	COMBINED USE OF GnRH AGONIST AND ANTAGONIST
DE19622457A1 (de)	1996-05-24	1997-11-27	Schering Ag	7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US6953774B2 (en) *	2000-08-11	2005-10-11	Applied Research Systems Ars Holding N.V.	Methods of inducing ovulation

2002
- 2002-04-17 KR KR10-2003-7013484A patent/KR20040025916A/ko not_active Ceased
- 2002-04-17 UA UA20031110268A patent/UA82648C2/uk unknown
- 2002-04-17 MX MXPA03009447A patent/MXPA03009447A/es not_active Application Discontinuation
- 2002-04-17 CA CA2444980A patent/CA2444980C/en not_active Expired - Fee Related
- 2002-04-17 SI SI200230747T patent/SI1383578T1/sl unknown
- 2002-04-17 PT PT02717919T patent/PT1383578E/pt unknown
- 2002-04-17 CN CNA028120825A patent/CN1551789A/zh active Pending
- 2002-04-17 IL IL15839602A patent/IL158396A0/xx unknown
- 2002-04-17 HU HU0304003A patent/HUP0304003A2/hu unknown
- 2002-04-17 AR ARP020101399A patent/AR034036A1/es unknown
- 2002-04-17 BR BR0208920-3A patent/BR0208920A/pt not_active IP Right Cessation
- 2002-04-17 HR HR20030839A patent/HRP20030839A2/hr not_active Application Discontinuation
- 2002-04-17 YU YU81203A patent/YU81203A/sh unknown
- 2002-04-17 CZ CZ20033107A patent/CZ20033107A3/cs unknown
- 2002-04-17 ES ES02717919T patent/ES2311599T3/es not_active Expired - Lifetime
- 2002-04-17 DE DE60229047T patent/DE60229047D1/de not_active Expired - Lifetime
- 2002-04-17 DK DK02717919T patent/DK1383578T3/da active
- 2002-04-17 EA EA200301128A patent/EA011310B1/ru not_active IP Right Cessation
- 2002-04-17 NZ NZ552873A patent/NZ552873A/en not_active IP Right Cessation
- 2002-04-17 AU AU2002249043A patent/AU2002249043B2/en not_active Ceased
- 2002-04-17 EE EEP200300505A patent/EE200300505A/xx unknown
- 2002-04-17 SK SK1424-2003A patent/SK14242003A3/sk unknown
- 2002-04-17 JP JP2002581041A patent/JP2004529924A/ja active Pending
- 2002-04-17 US US10/475,101 patent/US8008333B2/en not_active Expired - Fee Related
- 2002-04-17 EP EP02717919A patent/EP1383578B1/de not_active Expired - Lifetime
- 2002-04-17 AT AT02717919T patent/ATE409066T1/de active
- 2002-04-17 PL PL02366744A patent/PL366744A1/xx not_active Application Discontinuation
- 2002-04-17 WO PCT/CA2002/000527 patent/WO2002083241A1/en not_active Ceased
2003
- 2003-09-23 NO NO20034246A patent/NO20034246L/no not_active Application Discontinuation
- 2003-09-26 ZA ZA200307516A patent/ZA200307516B/en unknown
- 2003-11-07 BG BG108323A patent/BG108323A/bg unknown
2008
- 2008-12-12 CY CY20081101446T patent/CY1108648T1/el unknown

Also Published As

Publication number	Publication date
MXPA03009447A (es)	2004-05-24
PT1383578E (pt)	2008-10-08
IL158396A0 (en)	2004-05-12
US8008333B2 (en)	2011-08-30
HRP20030839A2 (en)	2005-08-31
EA200301128A1 (ru)	2004-04-29
DE60229047D1 (de)	2008-11-06
JP2004529924A (ja)	2004-09-30
DK1383578T3 (da)	2008-11-03
PL366744A1 (en)	2005-02-07
CY1108648T1 (el)	2014-04-09
NO20034246L (no)	2003-12-15
EA011310B1 (ru)	2009-02-27
AR034036A1 (es)	2004-01-21
SI1383578T1 (sl)	2008-12-31
HUP0304003A2 (hu)	2004-04-28
KR20040025916A (ko)	2004-03-26
SK14242003A3 (sk)	2004-03-02
YU81203A (sh)	2006-05-25
ZA200307516B (en)	2004-09-27
BR0208920A (pt)	2004-04-20
EP1383578B1 (de)	2008-09-24
EP1383578A1 (de)	2004-01-28
BG108323A (bg)	2004-12-30
CA2444980A1 (en)	2002-10-24
AU2002249043B2 (en)	2008-01-10
US20040171660A1 (en)	2004-09-02
CN1551789A (zh)	2004-12-01
ES2311599T3 (es)	2009-02-16
NO20034246D0 (no)	2003-09-23
CA2444980C (en)	2010-08-17
UA82648C2 (uk)	2008-05-12
WO2002083241A1 (en)	2002-10-24
NZ552873A (en)	2008-05-30
EE200300505A (et)	2004-02-16
CZ20033107A3 (en)	2004-03-17

Legal Events

Date

Code

Title

Description

2009-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1383578

Country of ref document: EP

Publication	Publication Date	Title
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE556059T1 (de)	2012-05-15	Pyrazolderivate zur behandlung von hiv
ATE275145T1 (de)	2004-09-15	Chinazolinderivate zur behandlung von tumoren
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE350375T1 (de)	2007-01-15	17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
ATE512163T1 (de)	2011-06-15	Verabreichung von mitteln zur behandlung von entzündungen
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE451921T1 (de)	2010-01-15	Phenylindole zur behandlung von hiv
ATE250605T1 (de)	2003-10-15	Piperidin verbindung zur behandlung von psoriasis
DE60019158D1 (de)	2005-05-04	Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
ATE296628T1 (de)	2005-06-15	Integrinhemmer zur behandlung von augenkrankheiten
DE60229959D1 (de)	2009-01-02	Kombinationstherapie zur behandlung von krebs
ATE279386T1 (de)	2004-10-15	Retinoide zur behandlung von emphysem
DE60325353D1 (de)	2009-01-29	Behandlung von mukositis
ATE469886T1 (de)	2010-06-15	17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen
DE60236743D1 (de)	2010-07-29	Zur behandlung androgenabhängiger krankheiten
EP1117431A4 (de)	2005-03-02	Behandlung von acidose
ATE493125T1 (de)	2011-01-15	Carbamatverbindungen zur behandlung von schmerz
DE50205466D1 (de)	2006-02-02	Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
ATE273276T1 (de)	2004-08-15	Cyclobutendion-derivate zur behandlung von artherosclerose
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
DE60103685D1 (de)	2004-07-15	Behandlung von Poriomania
DE60223707D1 (de)	2008-01-03	Calcium-l-threonat zur behandlung von knochenfrakturen
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus